Zentalis Pharmaceuticals (ZNTL) has priced its initial public offering (IPO) of 9.18M common shares at $18.00 per share yielding total proceeds of ~$165.2M.
Underwriters’ over-allotment is an additional 1,377,000 shares.
Closing date is April 7.
Trading kicks off today.
https://seekingalpha.com/news/3558109-zentalis-pharma-prices-ipo-18
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.